Product/Composition:- | Clonidine tablets |
---|---|
Strength:- | 0.1 mg, 0.2 mg, 0.3 mg |
Form:- | Tablets |
Reference Brands:- | Catapres(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Clonidine is an alpha-2 adrenergic agonist that decreases sympathetic nerve activity, leading to reduced blood pressure. It effectively treats hypertension, ADHD, and certain pain conditions. Benefits include rapid blood pressure control, decreased cardiovascular risk, improved symptom management, and supporting long-term cardiovascular health with convenience and fewer side effects.
Clonidine tablets, marketed as Catapres or generic in the US and EU, are approved for hypertension, ADHD, and pain management. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical and quality data, while the EMA ensures regional safety and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and global availability of clonidine tablets, helping healthcare providers effectively manage hypertension and related conditions worldwide.